Study: Technology helps decrease antipsychotic use in residents with dementia
By
Lois A. Bowers
Mar 09, 2016
Use of touchscreen computers with interfaces tailored to residents’ interests and abilities can result in a clinically significant decrease in the use of antipsychotic drugs among those with dementia,...
Senior living providers embrace role in CMS dementia care pilot program
By
Kimberly Bonvissuto
Jul 11, 2024
Senior living providers named participants in the federal government’s new dementia care pilot program said they are excited to be part of a new effort to support people living with dementia and their...
‘Digital life story’ tools are invaluable for memory care residents . . . but more need to know how...
By
Aaron Dorman
Mar 25, 2024
Giving older adults living with dementia digital tools to showcase their “life stories” is a tremendous addition to senior living and care communities, a new study shows.
Decision-making on antipsychotic medication use in assisted living needs system-level perspective: study
By
Kimberly Bonvissuto
Jan 25, 2023
Decisions on administering as-needed antipsychotic medications in assisted living/ residential care communities are based on attitudes, underlying morality and perceived expertise, requiring a system-level...
Get SMART: interactive whiteboard gives providers dynamic tool for engagement, socializing, developer...
By
Aaron Dorman
Feb 22, 2024
An interactive whiteboard developer is making its first foray into senior living and care spaces in the United States with a new pilot program in Colorado.
Act prioritizes fight against Alzheimer’s disease with state plan
By
Kimberly Bonvissuto
Sep 12, 2023
South Carolina’s adoption of a state Alzheimer’s plan is a “step forward,” according to senior living advocates.
Two Alzheimer’s drug trials halted
By
Lois A. Bowers
Mar 22, 2019
Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.
Providers identify 5 key areas for person-centered care of residents with dementia
By
Kimberly Bonvissuto
Nov 19, 2020
Several senior living companies were part of a roundtable that helped researchers identify five areas of change and developed person-centered practical solutions to address the unmet needs of people with...
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.